top of page

Topic

Antibody-Drug Conjugates (ADCs)

6 Podcasts on BackTable

GU Oncology: ASCO Highlights & Impacts on Practice
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 76  •  11 Aug 2026

GU Oncology: ASCO Highlights & Impacts on Practice

Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable Tumor Board Podcast, Dr. Katy Beckermann and Dr. Alan Tan break down the latest GU oncology highlights from ASCO, including key updates in prostate, renal cell, and urothelial carcinoma. They discuss new data supporting HRR/BRCA-focused therapy in HSPC, the importance of early biomarker testing, and ongoing debates about overtreatment and real-world practice impact.

More on Antibody-Drug Conjugates (ADCs)

Loading recent podcasts…

Tumor Board

Tumor Board # 76

Aug 10, 2026

with Dr. Alan Tan, Dr. Katy Beckermann

GU Oncology: ASCO Highlights & Impacts on Practice

Is GU oncology entering a new era of early intensification and precision therapy? On this episode of the BackTable...

Tumor Board

Tumor Board # 48

Feb 16, 2026

with Dr. Erika Hamilton, Dr. Lindsay Peterson

HER2-Positive Metastatic Breast Cancer: Treatment Insights & Protocols

In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...

2,000+ listens

Tumor Board

Tumor Board # 45

Jan 26, 2026

with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...

Tumor Board

Tumor Board # 52

Mar 23, 2026

with Dr. Sara Nunnery, Dr. Kate Baker

Antibody Drug Conjugates Across the HER2 Spectrum: From HER2-Positive to Ultralow Breast Cancer

Antibody-drug conjugates (ADCs) are expanding treatment options in breast cancer, but their use requires careful...

Urology

Urology # 287

Jan 29, 2026

with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan

Urothelial Carcinoma: Understanding ctDNA & Precision Medicine

Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...

1,500+ listens

Urology

Urology # 193

Oct 7, 2024

with Dr. Andrea Apolo, Dr. Bogdana Schmidt

Bladder Cancer Innovations: ESMO 2024 Highlights

Catch up on the latest breakthroughs in bladder cancer management. In this episode of the BackTable Urology Podcast,...

1,600+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page